Psyence Biomedical
(NASDAQ) PBM
Psyence Biomedical Financials at a Glance
Market Cap
$748,800
Revenue (TTM)
$0.00
Net Income (TTM)
$26.02M
EPS (TTM)
$0.00
P/E Ratio
-0.03
Dividend
$0.00
Beta (Volatility)
1.85 (High)
Dividend
$0.00
Beta (Volatility)
1.85 (High)
Price
$2.51
Volume
0
Open
$2.48
Price
$2.51
Volume
0
Open
$2.48
Previous Close
$2.51
Daily Range
$2.48 - $2.51
52-Week Range
$1.92 - $74.94
Dividend
$0.00
Beta (Volatility)
1.85 (High)
Price
$2.51
Volume
0
Open
$2.48
Previous Close
$2.51
Daily Range
$2.48 - $2.51
52-Week Range
$1.92 - $74.94
PBM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Psyence Biomedical
PBM Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
-54%
Return on Assets
14%
Earnings Yield
-33.33%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$748.80K
Shares Outstanding
299.50K
Volume
0
Short Interest
0.00%
Avg. Volume
203.28K
Financials (TTM)
Gross Profit
$4.27K
Operating Income
$3.66M
EBITDA
$1.03M
Operating Cash Flow
$3.73M
Capital Expenditure
$9.88K
Free Cash Flow
$3.74M
Cash & ST Invst.
$6.14M
Total Debt
$0.00
Psyence Biomedical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.33K
N/A
Gross Margin
0.00%
N/A
Market Cap
$748.80K
N/A
Market Cap/Employee
$62.40K
N/A
Employees
12
N/A
Net Income
$753.25K
-1098.6%
EBITDA
$749.17K
-799.9%
Quarterly Fundamentals
Net Cash
$7.20M
+716.2%
Accounts Receivable
$174.19K
+159.3%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
-100.0%
Return on Assets
13.83%
N/A
Return on Invested Capital
-54.49%
N/A
Free Cash Flow
$665.00
+99.2%
Operating Cash Flow
$662.00
+99.2%